Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $968000.0.

  • Dna X's Change in Inventory fell 8869.82% to $968000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 12069.15%. This contributed to the annual value of $5.0 million for FY2024, which is 9144.61% up from last year.
  • According to the latest figures from Q3 2025, Dna X's Change in Inventory is $968000.0, which was down 8869.82% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Change in Inventory registered a high of $8.6 million during Q3 2024, and its lowest value of -$2.7 million during Q4 2021.
  • Over the past 5 years, Dna X's median Change in Inventory value was -$180000.0 (recorded in 2022), while the average stood at $92894.7.
  • As far as peak fluctuations go, Dna X's Change in Inventory crashed by 38327.76% in 2024, and later soared by 12700000.0% in 2025.
  • Quarter analysis of 5 years shows Dna X's Change in Inventory stood at -$2.7 million in 2021, then skyrocketed by 93.44% to -$180000.0 in 2022, then skyrocketed by 1376.67% to $2.3 million in 2023, then tumbled by 181.77% to -$1.9 million in 2024, then skyrocketed by 151.52% to $968000.0 in 2025.
  • Its Change in Inventory stands at $968000.0 for Q3 2025, versus $1.3 million for Q2 2025 and -$2.3 million for Q1 2025.